The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
422 - Dear PAAB. The PAAB codes states that superlatives or special status cannot be used unless substantiation can be provided. What is the substantiation you are looking for? Is the monograph a source that would suffice?
-
PAAB code section 5.16 requires that claims of status be supported by authoritative sources. The terms of market authorization (e.g. product monograph) for the product in question would indeed be an acceptable source of support. As a courtesy, an alternative source of support could be authoritative consensus guidelines (provided the claim is consistent with the TMA). Note that the claim should be limited specifically to the meaning of the message in that reference. Also keep in mind that context is important to overall meaning.
